Feedback / Questions
ENV-294 - Enveda Biosci
https://www.businesswire.com/news/home/20250528125414/en/Enveda-Reports-Favorable-Phase-1-Safety-for-Novel-Oral-Anti-Inflammatory-Launches-Phase-1b-Trial-in-Atopic-Dermatitis
May 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next